[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

  • Product portfolio
  • Potentially strong market reviews
  • Competitive analytics
  • Prospect partners
  • Mergers and acquisitions project data
  • Latest trends across a particular industry area
  • Research and development strategies
  • The analysis of new customers
  • A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 5,853
Sort by:

Human Papillomavirus Protein E6 (E6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Human Papillomavirus Protein E6 (E6) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Human Papillomavirus Protein E6 (E6) Drugs in Develo...

May 2022 65 pages

Human Papillomavirus Protein E7 (E7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Human Papillomavirus Protein E7 (E7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Human Papillomavirus Protein E7 (E7) Drugs in Develo...

May 2022 77 pages

Human Parainfluenza Virus 3 Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Human Parainfluenza Virus 3 Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Human Parainfluenza Virus 3 Infections Drugs in Development by Stages, Ta...

May 2022 35 pages

Human SARS Coronavirus 2 RNA Dependent RNA Polymerase (RdRp or EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Human SARS Coronavirus 2 RNA Dependent RNA Polymerase (RdRp or EC 2.7.7.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Human SARS Co...

May 2022 38 pages

Human SARS coronavirus Spike Glycoprotein (E2 or Peplomer Protein or S) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Human SARS coronavirus Spike Glycoprotein (E2 or Peplomer Protein or S) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Human SARS corona...

May 2022 40 pages

Hutchinson-Gilford Progeria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hutchinson-Gilford Progeria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hutchinson-Gilford Progeria Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 35 pages

Hyperargininemia (Arginase I Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hyperargininemia (Arginase I Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hyperargininemia (Arginase I Deficiency) Drugs in Development by Stages...

May 2022 36 pages

Hyperlipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Hyperlipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hyperlipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 146 pages

Hyperphosphatemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hyperphosphatemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hyperphosphatemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 45 pages

Hypersomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hypersomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hypersomnia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 42 pages

Hypertriglyceridemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hypertriglyceridemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hypertriglyceridemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 64 pages

Hypertrophic Scars Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hypertrophic Scars Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hypertrophic Scars Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 41 pages

Hypoxia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hypoxia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hypoxia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an over...

May 2022 41 pages

Hypoxic-Ischemic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hypoxic-Ischemic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hypoxic-Ischemic Encephalopathy Drugs in Development by Stages, Target, MoA, RoA...

May 2022 42 pages

Ichthyosis Vulgaris Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Ichthyosis Vulgaris Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Ichthyosis Vulgaris Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 35 pages

Idiopathic (Essential) Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Idiopathic (Essential) Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Idiopathic (Essential) Hypertension Drugs in Development by Stages, Target,...

May 2022 63 pages

Idiopathic Short Stature Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Idiopathic Short Stature Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Idiopathic Short Stature Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 36 pages

IgA Nephropathy (Bergers Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

IgA Nephropathy (Bergers Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY IgA Nephropathy (Berger's Disease) Drugs in Development by Stages, Target, MoA...

May 2022 73 pages

IgG Receptor FcRn Large Subunit p51 (IgG Fc Fragment Receptor Transporter Alpha Chain or Neonatal Fc Receptor or FCGRT or FCRN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

IgG Receptor FcRn Large Subunit p51 (IgG Fc Fragment Receptor Transporter Alpha Chain or Neonatal Fc Receptor or FCGRT or FCRN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA,...

May 2022 38 pages

IkappaB Kinase (IKK or EC 2.7.11.10) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

IkappaB Kinase (IKK or EC 2.7.11.10) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY IkappaB Kinase (IKK or EC 2.7.11.10) Drugs in Develo...

May 2022 49 pages

Immunoglobulin G4-Related Disease (IgG4-RD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Immunoglobulin G4-Related Disease (IgG4-RD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Immunoglobulin G4-Related Disease (IgG4-RD) Drugs in Development by...

May 2022 38 pages

Inducible T Cell Costimulator (Activation Inducible Lymphocyte Immunomediatory Molecule or CD278 or ICOS) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Inducible T Cell Costimulator (Activation Inducible Lymphocyte Immunomediatory Molecule or CD278 or ICOS) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key...

May 2022 39 pages

Infantile Spasm (West Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Infantile Spasm (West Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Infantile Spasm (West Syndrome) Drugs in Development by Stages, Target, MoA, RoA...

May 2022 39 pages

Infectious Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Infectious Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Infectious Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key...

May 2022 42 pages

Infectious Endophthalmitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Infectious Endophthalmitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Infectious Endophthalmitis Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 36 pages

Inflammatory Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Inflammatory Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Inflammatory Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 170 pages

Influenza M2 Proton Channel Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Influenza M2 Proton Channel Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Influenza M2 Proton Channel Drugs in Development by Therapy A...

May 2022 36 pages

Influenzavirus A Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Influenzavirus A Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Influenzavirus A Infections Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 269 pages

Inherited Mitochondrial Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Inherited Mitochondrial Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Inherited Mitochondrial Disorders Drugs in Development by Stages, Target, MoA,...

May 2022 46 pages

Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Insulin Like Growth...

May 2022 65 pages

Insulin Receptor (IR or CD220 or INSR or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Insulin Receptor (IR or CD220 or INSR or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Insulin Receptor (IR or CD220 or IN...

May 2022 219 pages

Integrin Alpha 2b (GPalpha IIb or Platelet Membrane Glycoprotein IIb or CD41 or ITGA2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Alpha 2b (GPalpha IIb or Platelet Membrane Glycoprotein IIb or CD41 or ITGA2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY I...

May 2022 36 pages

Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Integrin Alpha V (...

May 2022 67 pages

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type an...

May 2022 48 pages

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Integrin Beta 3 (P...

May 2022 57 pages

Integrin Beta 5 (ITGB5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Beta 5 (ITGB5) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Integrin Beta 5 (ITGB5) Drugs in Development by Therapy Areas and...

May 2022 35 pages

Integrin Beta 8 (ITGB8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Integrin Beta 8 (ITGB8) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Integrin Beta 8 (ITGB8) Drugs in Development by Therapy Areas and...

May 2022 37 pages

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Inte...

May 2022 39 pages

Interferon Alpha-Beta Receptor 1 (Cytokine Receptor Class II Member 1 or Cytokine Receptor Family 2 Member 1 or Type I Interferon Receptor 1 or IFNAR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Alpha-Beta Receptor 1 (Cytokine Receptor Class II Member 1 or Cytokine Receptor Family 2 Member 1 or Type I Interferon Receptor 1 or IFNAR1) Drugs in Development by Therapy Areas and Indica...

May 2022 82 pages

Interferon Alpha-Beta Receptor 2 (Interferon Alpha Binding Protein or Type I Interferon Receptor 2 or IFNAR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Alpha-Beta Receptor 2 (Interferon Alpha Binding Protein or Type I Interferon Receptor 2 or IFNAR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and...

May 2022 72 pages

Interferon Alpha (IFNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Alpha (IFNA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interferon Alpha (IFNA) Drugs in Development by Therapy Areas and...

May 2022 41 pages

Interferon Beta (Fibroblast Interferon or IFNB or IFNB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Beta (Fibroblast Interferon or IFNB or IFNB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interferon Beta (Fibroblast Inte...

May 2022 36 pages

Interferon Gamma (Immune Interferon or IFNG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Gamma (Immune Interferon or IFNG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interferon Gamma (Immune Interferon or IFNG)...

May 2022 37 pages

Interferon Gamma Receptor 1 (CDw119 or CD119 or IFNGR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interferon Gamma Receptor 1 (CDw119 or CD119 or IFNGR1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interferon Gamma Receptor 1 (CDw1...

May 2022 35 pages

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 1 Alpha (IL 1 Alp...

May 2022 40 pages

Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 1 Beta (IL 1 Beta or Cata...

May 2022 56 pages

Interleukin 1 Receptor Accessory Protein (Interleukin 1 Receptor 3 or IL1R3 or IL1RAP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 1 Receptor Accessory Protein (Interleukin 1 Receptor 3 or IL1R3 or IL1RAP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY In...

May 2022 38 pages

Interleukin 1 Receptor (IL1R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 1 Receptor (IL1R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 1 Receptor (IL1R) Drugs in Development by Thera...

May 2022 73 pages

Interleukin 1 Receptor Like 2 (IL 36 Receptor or Interleukin 1 Receptor Related Protein 2 or IL1RL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 1 Receptor Like 2 (IL 36 Receptor or Interleukin 1 Receptor Related Protein 2 or IL1RL2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Play...

May 2022 38 pages

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Interleukin 10 (Cyt...

May 2022 49 pages

Filters

Search

Categories

2,264
2,910
126
9
6
1
1
1
4
522
3
6

Publishers

5,853

Regions

5,853

Price

Date

Pages

Offers